These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 22836068

  • 1. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
    Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.
    J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
    [Abstract] [Full Text] [Related]

  • 2. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE.
    Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
    [Abstract] [Full Text] [Related]

  • 3. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J, Fonseca VA, Garvey WT, Goldberg RB, Handelsman Y, Abby SL, Lai YL, Jin X, Misir S, Nagendran S, Jones MR.
    Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
    [Abstract] [Full Text] [Related]

  • 4. Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes.
    Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR, Nagendran S.
    Postgrad Med; 2012 Jul; 124(4):7-13. PubMed ID: 22913889
    [Abstract] [Full Text] [Related]

  • 5. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE, Goldberg RB, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Oct 13; 168(18):1975-83. PubMed ID: 18852398
    [Abstract] [Full Text] [Related]

  • 6. Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
    Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR.
    Postgrad Med; 2012 Jul 13; 124(4):14-20. PubMed ID: 22913890
    [Abstract] [Full Text] [Related]

  • 7. Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus.
    Rosenson RS, Rigby SP, Jones MR, Chou HS.
    Cardiovasc Drugs Ther; 2014 Jun 13; 28(3):229-36. PubMed ID: 24710760
    [Abstract] [Full Text] [Related]

  • 8. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I, Abby SL, Misir S, Nagendran S.
    Metab Syndr Relat Disord; 2009 Jun 13; 7(3):255-8. PubMed ID: 19344229
    [Abstract] [Full Text] [Related]

  • 9. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
    Rosenson RS, Abby SL, Jones MR.
    Atherosclerosis; 2009 Jun 13; 204(2):342-4. PubMed ID: 18996525
    [Abstract] [Full Text] [Related]

  • 10. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.
    Clin Ther; 2007 Jan 13; 29(1):74-83. PubMed ID: 17379048
    [Abstract] [Full Text] [Related]

  • 11. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL.
    Endocr Pract; 2010 Jan 13; 16(4):617-28. PubMed ID: 20634176
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
    Gavin JR, Jones MR, Ford DM, Truitt KE.
    Drugs Aging; 2014 Jun 13; 31(6):461-70. PubMed ID: 24777691
    [Abstract] [Full Text] [Related]

  • 13. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH, Donovan JM, Misir S, Jones MR.
    Am J Cardiovasc Drugs; 2010 Jun 13; 10(5):305-14. PubMed ID: 20860413
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia.
    McKenney J, Jones M, Abby S.
    Curr Med Res Opin; 2005 Sep 13; 21(9):1403-12. PubMed ID: 16197659
    [Abstract] [Full Text] [Related]

  • 18. Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
    Goldberg RB, Rosenson RS, Hernandez-Triana E, Misir S, Jones MR.
    Diab Vasc Dis Res; 2013 May 13; 10(3):256-62. PubMed ID: 23152373
    [Abstract] [Full Text] [Related]

  • 19. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR, Hagan MA.
    Pharmacoeconomics; 2010 May 13; 28(9):765-80. PubMed ID: 20799756
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of colesevelam in combination with pioglitazone in patients with type 2 diabetes mellitus.
    Rosenstock J, Truitt KE, Baz-Hecht M, Ford DM, Tao B, Chou HS.
    Horm Metab Res; 2014 Dec 13; 46(13):943-9. PubMed ID: 25054436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.